Miniatura

Fitxers

Cuervo G.pdf (470.01 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2025-03-01

Llicència de publicació

cc-by-nc (c) Cuervo Requena, Guillermo et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/219730

Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial.

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1007/s40121-025-01110-9

Resum

The POET trial demonstrated that moving from intravenous to oral antibiotics in stable patients with left-sided infective endocarditis (IE) was noninferior to fully parenteral treatment. However, it did not compare outpatient strategies. The OraPAT-IE GAMES trial is a noninferiority, multicenter, randomized, open-label study aimed to compare partial oral versus outpatient parenteral antibiotic therapy (OPAT) for consolidation of antibiotic treatment in left-sided IE. A total of 342 stable patients with IE caused by selected micro-organisms will eventually be included. After a minimum of 10 days of parenteral treatment, stable patients are randomized to oral therapy or OPAT. The primary end-point is a composite of all-cause mortality, unplanned cardiac surgery, relapse of positive blood cultures and/or unplanned hospital admission. Patients are followed-up for 6 months after completing antibiotic therapy. This trial seeks to demonstrate the equivalent efficacy of the two outpatient strategies currently available for stable patients with IE in the consolidation phase of antibiotic treatment. In a global context of limited healthcare resources and a sustained increase in elderly and frail patients, it is of great importance to demonstrate the effectiveness and safety of outpatient management strategies that could reduce the duration of conventional hospitalizations with their potential complications and inherent costs. EudraCT: 2020-001024-34. gov identifier: NCT05398679.

Matèries

Assaigs clínics, Endocarditis, Terapèutica

Matèries (anglès)

Clinical trials, Endocarditis, Therapeutics

Citació

Col·leccions

Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

CUERVO REQUENA, Guillermo, HERNÁNDEZ MENESES, Marta, ALARCÓN, A. de, LUQUE MÁRQUEZ, R., ALONSO SOCAS, M. m., LÓPEZ LIROLA, A., GONZÁLEZ RAMALLO, V., GOIKOETXEA AGIRRE, A. j., NICOLÁS, David, GOENAGA, M. á., MERINO CABRERA, Esperanza, ESCRIHUELA VIDAL, Francesc, MARTÍN DÁVILA, P., LOECHES, B., BOIX PALOP, Lucia, GASCH, O., CAMPRECIOS, M., HERNÁNDEZ TORRES, A., GARCÍA ÁLVAREZ, L., PAJARÓN, M., RIBAS, M. a., BLANES HERNÁNDEZ, R., LÓPEZ MONTESINOS, I., LÓPEZ CORTÉS, L. e., VIDAL, B., FERNÁNDEZ PITTOL, M., NAVARRO, D., MORENO, A., SALA, C., AMBROSIONI CZYRKO, Juan carlos enrique, MIRÓ MEDA, José m. (josé maría), OraPAT-IE GAMES Investigators. Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial.. _Infectious diseases and therapy_. 2025. [consulta: 21 de gener de 2026]. ISSN: 2193-6382. [Disponible a: https://hdl.handle.net/2445/219730]

Exportar metadades

JSON - METS

Compartir registre